A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yang Yu, MD
Medical Director
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Provincial Cancer Hospital
Hefei, Anhui, China
- Beijing Tongren Hospital.Cmu
Beijing, Beijing Municipality, China
- Peking University Third Hospital
Beijing, Beijing Municipality, China
- Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- Hubei Cancer Hospital
Wuhan, Hubei, China
- Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
- Jiangsu Province Hospital
Nanjing, Jiangsu, China
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- Tianjin Medical Universisity Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
- the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Aug 2020
- Primary completion
- 30 Dec 2025
- Completion
- 30 Dec 2025
- Last update posted
- 5 Jan 2026
- Registered enrollment
- 56
- Registry id
- NCT04425070
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.